Cargando…
N-(2′-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells
N-(2′-Hydroxyphenyl)-2-propylpentanamide (OH-VPA) is a valproic acid (VPA) derivative with improved antiproliferative activity toward breast cancer (MCF-7, MDA-MB-231, and SKBr3) and human cervical cancer cell lines (HeLa) compared to that of VPA. However, the pharmacological mechanism of OH-VPA act...
Autores principales: | Contis-Montes de Oca, Arturo, Rodarte-Valle, Estefanía, Rosales-Hernández, Martha Cecilia, Abarca-Rojano, Edgar, Rojas-Hernández, Saúl, Fragoso-Vázquez, Manuel Jonathan, Mendieta-Wejebe, Jessica Elena, Correa-Basurto, Ana María, Vázquez-Moctezuma, Ismael, Correa-Basurto, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6161798/ https://www.ncbi.nlm.nih.gov/pubmed/30279967 http://dx.doi.org/10.18632/oncotarget.26077 |
Ejemplares similares
-
Correction: N-(2´-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells
por: Contis-Montes de Oca, Arturo, et al.
Publicado: (2019) -
N-(2′-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Inhibits HDAC1 and Increases the Translocation of HMGB1 Levels in Human Cervical Cancer Cells
por: Sixto-López, Yudibeth, et al.
Publicado: (2020) -
Hepatotoxic Evaluation of N-(2-Hydroxyphenyl)-2-Propylpentanamide: A Novel Derivative of Valproic Acid for the Treatment of Cancer
por: Correa Basurto, Ana María, et al.
Publicado: (2023) -
PAMAM-G4 protect the N-(2-hydroxyphenyl)-2-propylpentanamide (HO-AAVPA) and maintain its antiproliferative effects on MCF-7
por: Ortiz-Morales, Alma Alicia, et al.
Publicado: (2023) -
Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines
por: Estrada-Pérez, Alan Rubén, et al.
Publicado: (2023)